Robert S. Witte

1.3k total citations
30 papers, 964 citations indexed

About

Robert S. Witte is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Robert S. Witte has authored 30 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Robert S. Witte's work include Renal cell carcinoma treatment (5 papers), Cancer therapeutics and mechanisms (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Robert S. Witte is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Cancer therapeutics and mechanisms (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Robert S. Witte collaborates with scholars based in United States, South Africa and Philippines. Robert S. Witte's co-authors include Paul Elson, Donald L. Trump, Patrick J. Loehrer, Bartholomew R. Bono, Robert Dreicer, Richard H. Knop, D L Trump, J. Thomas Rosenthal, Ronald H. Blum and Douglass C. Tormey and has published in prestigious journals such as The Journal of Chemical Physics, Journal of Clinical Oncology and Journal of Applied Physics.

In The Last Decade

Robert S. Witte

30 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert S. Witte United States	14	402	378	326	262	127	30	964
Michael Franks United States	14	280 0.7×	138 0.4×	265 0.8×	419 1.6×	107 0.8×	34	1.4k
Richard H. Knop United States	16	161 0.4×	134 0.4×	401 1.2×	223 0.9×	86 0.7×	31	1.0k
K. M. Schrott Germany	18	477 1.2×	288 0.8×	1.1k 3.5×	351 1.3×	163 1.3×	57	1.6k
Akira Irie Japan	18	331 0.8×	157 0.4×	349 1.1×	313 1.2×	81 0.6×	78	1.3k
Raya S. Brown United States	10	235 0.6×	217 0.6×	159 0.5×	372 1.4×	376 3.0×	18	1.1k
Uwe Treiber Germany	21	812 2.0×	233 0.6×	630 1.9×	222 0.8×	145 1.1×	45	1.6k
Norman M. Bleehen United Kingdom	18	221 0.5×	380 1.0×	73 0.2×	289 1.1×	159 1.3×	56	1.1k
Michael J. Manyak United States	24	984 2.4×	201 0.5×	400 1.2×	258 1.0×	146 1.1×	84	2.0k
Samuel E. Halpern United States	20	252 0.6×	384 1.0×	160 0.5×	266 1.0×	30 0.2×	84	1.5k
Hong Koo Ha South Korea	23	376 0.9×	220 0.6×	362 1.1×	471 1.8×	203 1.6×	98	1.3k

Countries citing papers authored by Robert S. Witte

Since Specialization

Citations

This map shows the geographic impact of Robert S. Witte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Witte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Witte more than expected).

Fields of papers citing papers by Robert S. Witte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Witte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Witte. The network helps show where Robert S. Witte may publish in the future.

Co-authorship network of co-authors of Robert S. Witte

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Witte. A scholar is included among the top collaborators of Robert S. Witte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Witte. Robert S. Witte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schaible, Hans‐Georg, David T. Felson, John S. Witte, & Robert S. Witte. (2009). Pain in Osteoarthritis. 2 indexed citations

Hoang, Tien, KyungMann Kim, Anthony J. Jaslowski, et al.. (2003). Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer. Lung Cancer. 42(1). 97–102. 54 indexed citations

Witte, Robert S., et al.. (2001). Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma. Cancer. 91(5). 1020–1028. 7 indexed citations

Witte, Robert S., Stuart R. Lipsitz, Robert F. Asbury, et al.. (1999). A Phase II Trial of Homoharringtonine and Caracemide in the Treatment of Patients with Advanced Large Bowel Cancer. Investigational New Drugs. 17(2). 173–177. 16 indexed citations

Witte, Robert S., et al.. (1998). Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trial. Investigational New Drugs. 16(2). 191–195. 38 indexed citations

Witte, Robert S., Louise Ryan, Allan J. Schutt, Paul P. Carbone, & Paul F. Engstrom. (1998). Pala Versus Streptozotocin, Doxorubicin, and Meccnu in the Treatment of Patients With Advanced Pancreatic Carcinoma. Investigational New Drugs. 16(4). 315–318. 1 indexed citations

Witte, Robert S., Paul Elson, Bartholomew R. Bono, et al.. (1997). Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma.. Journal of Clinical Oncology. 15(2). 589–593. 155 indexed citations

Yeap, B.Y., Thomas P. Davis, Ronald H. Blum, et al.. (1996). Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.. Journal of Clinical Oncology. 14(8). 2250–2257. 104 indexed citations

Witte, Robert S., et al.. (1996). A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancer. Investigational New Drugs. 14(4). 409–413. 17 indexed citations

10.

Witte, Robert S., et al.. (1996). A phase II trial of melphalan or thioguanine in the treatment of patients with advanced renal cell cancer. Urologic Oncology Seminars and Original Investigations. 2(3). 96–98. 2 indexed citations

11.

Witte, Robert S., Traci Leong, Marc S. Ernstoff, et al.. (1995). A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinoma. Investigational New Drugs. 13(3). 241–247. 5 indexed citations

12.

Witte, Robert S., Beow Y. Yeap, & Donald L. Trump. (1994). Trimetrexate in advanced hormone-refractory prostate cancer. Investigational New Drugs. 12(3). 255–258. 6 indexed citations

13.

Witte, Robert S., et al.. (1994). An eastern cooperative oncology group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma. Cancer. 73(3). 688–691. 41 indexed citations

14.

Witte, Robert S., Paul Elson, George T. Bryan, & Donald L. Trump. (1992). Trimetrexate in advanced renal cell carcinoma. Investigational New Drugs. 10(1). 51–54. 11 indexed citations

15.

Witte, Robert S., et al.. (1992). Evaluation of deoxycoformycin in patients with advanced renal cell carcinoma. Investigational New Drugs. 10(1). 49–50. 5 indexed citations

16.

Falkson, Geoffrey, et al.. (1991). Long-term survival of patients treated with combination chemotherapy for metastatic breast cancer. European Journal of Cancer and Clinical Oncology. 27(8). 973–977. 31 indexed citations

17.

Chang, Alex Y. C., Robert S. Witte, D C Tormey, & Guillermo Ramírez. (1984). Evaluation of vindesine in patients with refractory small cell lung cancer.. PubMed. 68(11). 1407–8. 2 indexed citations

18.

Witte, Robert S., Alex Y. C. Chang, & D C Tormey. (1982). Vindesine sulfate (VND): A phase II trial in small cell bronchogenic carcinoma (SCCL). 1. 2 indexed citations

19.

Witte, Robert S.. (1964). Long-term effects of patterned reward schedules.. Journal of Experimental Psychology. 68(6). 588–594. 12 indexed citations

20.

Witte, Robert S.. (1959). A stimulus-trace hypothesis for statistical learning theory.. Journal of Experimental Psychology. 57(5). 273–283. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact